Patent details

EP3052487 Title: STABILIZED EFINACONAZOLE COMPOSITIONS

Basic Information

Publication number:
EP3052487
PCT Application Number:
US2014058911
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP148511330
PCT Publication Number:
WO2015051183
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
STABILIZED EFINACONAZOLE COMPOSITIONS
French Title of Invention:
COMPOSITIONS D'ÉFINACONAZOLE STABILISÉE
German Title of Invention:
STABILISIERTE EFINACONAZOLZUSAMMENSETZUNGEN
SPC Number:

Dates

Filing date:
02/10/2014
Grant date:
05/09/2018
EP Publication Date:
10/08/2016
PCT Publication Date:
09/04/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/09/2018
EP B1 Publication Date:
05/09/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
02/10/2018
Expiration date:
02/10/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/08/2018
 
 

Name:
Dow Pharmaceutical Sciences, Inc.
Address:
1330 Redwood Way, Petaluma, CA 94954-6542, United States (US)

Inventor

1

Name:
DESAI, Nayan
Address:
United States (US)

2

Name:
BHATT, Varsha
Address:
United States (US)

3

Name:
PILLAI, Radhakrishnan
Address:
United States (US)

Priority

1

Priority Number:
201361886569 P
Priority Date:
03/10/2013
Priority Country:
United States (US)

2

Priority Number:
201461922867 P
Priority Date:
01/01/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/00; A61K 9/06; A61K 9/08; A61K 31/454; A61K 47/12; C07D 405/00; A61K 47/10; A61K 47/18;

Publication

European Patent Bulletin

Issue number:
201836
Publication date:
05/09/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
28/02/2019 Outgoing Correspondence 1